|
Volumn 124, Issue 4, 2004, Pages 495-496
|
When should macrolides be used in the treatment of upper respiratory tract infections;Når skal makrolider brukes ved øvre luftveisinfeksjoner?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZITHROMYCIN;
CLARITHROMYCIN;
ERYTHROMYCIN;
MACROLIDE;
PENICILLIN G;
SPIRAMYCIN;
TELITHROMYCIN;
ANTIBIOTIC THERAPY;
BACTERIUM IDENTIFICATION;
DRUG CHOICE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG STRUCTURE;
HAEMOPHILUS INFLUENZAE;
MEDICAL DECISION MAKING;
MINIMUM INHIBITORY CONCENTRATION;
PENICILLIN ALLERGY;
SHORT SURVEY;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
STREPTOCOCCUS PYOGENES;
TREATMENT PLANNING;
UPPER RESPIRATORY TRACT INFECTION;
ARTICLE;
BACTERIAL INFECTION;
HUMAN;
MICROBIOLOGY;
PERTUSSIS;
PRACTICE GUIDELINE;
RESPIRATORY TRACT INFECTION;
HUMANS;
MACROLIDES;
MYCOPLASMA INFECTIONS;
PRACTICE GUIDELINES;
RESPIRATORY TRACT INFECTIONS;
WHOOPING COUGH;
|
EID: 1442327342
PISSN: 00292001
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (2)
|
References (11)
|